From Dr. Bredesen
Chief Science Officer
January 17, 2023•From Dr. Bredesen, News
In his blog "Only 'Til I Need Glasses," Dr. Bredesen encourages you to protect your brain health by making one significant change in 2023 to prevent cognitive decline rather than wait for symptoms to develop. Read More »
December 19, 2022•From Dr. Bredesen, Insider Strategies, News
Dr. Bredesen shares tips to survive and mitigate exposures while traveling by air for the holidays from toxins, stress, sitting for too long, poor dietary options, toxins, and pathogens, all of which can damage your cognition. Read More »
December 9, 2022•From Dr. Bredesen, News
Holiday Traditions and Beliefs
In his blog "Holiday Traditions and Beliefs," Dr. Bredesen discusses the near-mythical recent press coverage of the AD drug lecanemab, which simply slows decline but doesn't improve cognition and comes with dangerous side effects. Read More »
October 20, 2022•From Dr. Bredesen, News
In his blog, The Road Less Traveled, Dr. Bredesen recounts the journey that he and his team have taken, devoting years of research into identifying the causes and ultimate treatment of Alzheimer's — a major shift from a drug-based monotherapeutic approach towards a multifactorial path addressing the multiple causes and chronic diseases that lead to cognitive decline. Read More »
September 20, 2022•From Dr. Bredesen, News
In his blog, "Sowing the Seeds," Dr. Bredesen talks about how from birth, our environment, nutrition, and sedentary lifestyles, some of the drivers of cognitive decline, can be corrected long before they manifest into AD. Read More »
August 23, 2022•From Dr. Bredesen, News
In his blog “Smiling From Era to Era,” Dr. Bredesen discusses the transition from the Pharmaceutical Era, which targets a single target in AD (amyloid), to the Precision Era which targets the many contributors of cognitive decline and offers an individualized treatment approach. Read More »
August 3, 2022•From Dr. Bredesen, News
Criticism of the Bredesen Protocol
Dr. Bredesen addresses the destructive criticism of his successful, clinically proven approach to treating early-stage dementia. Read More »
July 25, 2022•From Dr. Bredesen, News
Milestones, and Miles of Stones
Dr. Bredesen outlines his 30-year research journey, which has led to his latest clinical trial's publication in JAD, talking about the milestones met, despite naysayers occasionally throwing stones and questioning its validity. Read More »